H.R. 5463 · 117th Congress

Drug Pricing Transparency and Accountability Act

Stage
In committee
Sponsor
Matthew Rosendale
Introduced
2021-09-30
Latest action
2021-10-01 · Referred to the Subcommittee on Health.

Action history

  1. 2021-10-01Referred to the Subcommittee on Health.
  2. 2021-09-30Introduced in House
  3. 2021-09-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2021-09-30Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.